Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From July 30, 1993 to September 20, 1993
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
200, 500, 1000, 2500, 5000 and 7500 µg/plate
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Remarks:
Water and DMSO
True negative controls:
yes
Positive controls:
yes
Positive control substance:
sodium azide
N-ethyl-N-nitro-N-nitrosoguanidine
mitomycin C
other: Acridine mutagen, 2-amino anthacene, Daunomycine,
Details on test system and experimental conditions:
Batch number: 3507/15
Key result
Species / strain:
E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Conclusions:
Under the study conditions, the substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay.
Executive summary:

A study was conducted to determine the mutagenic potential of the substance according to OECD Guideline 471, in compliance with GLP. The bacterial strains Salmonella typhimurium TA 1535, TA 1537, TA 98,TA 100 and E. coli strains WP2P and WP2PuvrA were tested with following test substance concentrations: 0, 200, 500, 1000, 2500, 5000 and 7500 µg/plate with and without metabolic activation. In two separate assays, the compound did not induce any significant reproducible increase in the observed number of revertant colonies in strains TA 1535, TA 1537, TA 98, TA 100 and E. coli strains either in the presence or absence of a metabolising system (S9). Although some increases in colony numbers were observed with the strains TA1535 and WP2P without S9, this did not exceed twice the background level in any instance and were not dose -related. In each experiment the positive controls responded as expected indicating that the assay performed satisfactorily. Under the study conditions, the substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay (Callander, 1993).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

In vitro:

A study was conducted to determine the mutagenic potential of the substance according to OECD Guideline 471, in compliance with GLP. The bacterial strains Salmonella typhimurium TA 1535, TA 1537, TA 98,TA 100 and E. coli strains WP2P and WP2PuvrA were tested with following test substance concentrations: 0, 200, 500, 1000, 2500, 5000 and 7500 µg/plate with and without metabolic activation. In two separate assays, the compound did not induce any significant reproducible increase in the observed number of revertant colonies in strains TA 1535, TA 1537, TA 98, TA 100 and E. coli strains either in the presence or absence of a metabolising system (S9). Although some increases in colony numbers were observed with the strains TA1535 and WP2P without S9, this did not exceed twice the background level in any instance and were not dose -related. In each experiment the positive controls responded as expected indicating that the assay performed satisfactorily. Under the study conditions, the substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay (Callander, 1993).

Justification for classification or non-classification

Based on the results of in vitro gene mutation study in bacteria, no conclusion could be reached on classification for mutagenicity according to EU CLP (EC 1272/2008) criteria.